Zobrazeno 1 - 10
of 110
pro vyhledávání: '"Massi Benedetti, Massimo"'
Autor:
Colhoun, Helen, Danne, Thomas, Due-Christensen, Mette, Eeg-Olofsson, Katarina, Fagherazzi, Guy, Haustein, Robert, Klok, Rogier, Levrat-Guillen, Fleur, Massi Benedetti, Massimo, Mata, Manel, Pall, Jaivir, Soderberg, Jeannette, Vedin, Ola, Wilson, Petra, Khunti, Kamlesh, Mathieu, Chantal, Torbeyns, Bart, Del Prato, Stefano, Heine, Robert
Publikováno v:
In The Lancet Diabetes & Endocrinology February 2023 11(2):70-72
Autor:
Carinci, Fabrizio, Štotl, Iztok, Cunningham, Scott, Poljicanin, Tamara, Pristas, Ivan, Traynor, Vivie, Olympios, George, Scoutellas, Vasos, Azzopardi, Joseph, Doggen, Kris, Sándor, János, Adany, Roza, Løvaas, Karianne, Jarosz- Chobot, Przemka, Polanska, Joanna, Pruna, Simion, de Lusignan, Simon, Monesi, Marcello, Di Bartolo, Paolo, Scheidt-Nave, Christa Elisabeth, Heidemann, Christin, Zucker, Inbar, Maurina, Anita, Lepiksone, Jana, Rossing, Peter, Arffman, Martti, Keskimäki, Ilmo, Gudbjornsdottir, Soffia, Di Iorio, Concetta Tania, Dupont, Elisabeth, de Sabata, Stella, Klazinga, Niek, Massi Benedetti, Massimo
Background: Registries and data sources contain information that can be used on an ongoing basis to improve quality of care and outcomes of people with diabetes. As a specific task of the EU Bridge Health project, we carried out a survey of diabetes-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::ba80b317846fc6ddb13ed7d62f37da4f
https://trepo.tuni.fi/handle/10024/144902
https://trepo.tuni.fi/handle/10024/144902
Autor:
Erdmann, Erland, Dormandy, John A. †, Charbonnel, Bernard ‡, Massi-Benedetti, Massimo §, Moules, Ian K. ∥, Skene, Allan M. ¶
Publikováno v:
In Journal of the American College of Cardiology 1 May 2007 49(17):1772-1780
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Dormandy, John A, Charbonnel, Bernard, Eckland, David JA, Erdmann, Erland, Massi-Benedetti, Massimo, Moules, Ian K, Skene, Allan M, Tan, Meng H, Lefèbvre, Pierre J, Murray, Gordon D, Standl, Eberhard, Wilcox, Robert G, Wilhelmsen, Lars, Betteridge, John, Birkeland, Kåre, Golay, Alain, Heine, Robert J, Korányi, László, Laakso, Markku, Mokáň, Marián, Norkus, Antanas, Pirags, Valdis, Podar, Toomas, Scheen, André, Scherbaum, Werner, Schernthaner, Guntram, Schmitz, Ole, Škrha, Jan, Smith, Ulf, Tatoň, Jan
Publikováno v:
In The Lancet 2005 366(9493):1279-1289
Autor:
Massi-Benedetti, Massimo
Publikováno v:
In Clinical Therapeutics 2003 25(3):799-816
Autor:
Khunti, Kamlesh, Mathieu, Chantal, Torbeyns, Bart, Del Prato, Stefano, Heine, Robert, Colhoun, Helen, Danne, Thomas, Due-Christensen, Mette, Eeg-Olofsson, Katarina, Fagherazzi, Guy, Haustein, Robert, Klok, Rogier, Levrat-Guillen, Fleur, Massi Benedetti, Massimo, Mata, Manel, Pall, Jaivir, Soderberg, Jeannette, Vedin, Ola, Wilson, Petra
Publikováno v:
The Lancet Diabetes & Endocrinology; February 2023, Vol. 11 Issue: 2 p70-72, 3p
Autor:
Massi-Benedetti Massimo, Erny-Albrecht Katrina M, Goodall Gordon, Scherbaum Werner A, Erdmann Erland, Valentine William J
Publikováno v:
Cost Effectiveness and Resource Allocation, Vol 7, Iss 1, p 9 (2009)
Abstract Background The aim of this study was to project health-economic outcomes relevant to the German setting for the addition of pioglitazone to existing treatment regimens in patients with type 2 diabetes, evidence of macrovascular disease and a
Externí odkaz:
https://doaj.org/article/f6a24f3cbf244fb0aaab273b60b4b68c
Autor:
Arleth, Tom, Andreassen, Steen, Orsini-Federici, Marco, Timi, Alessia, Massi-Benedetti, Massimo
Publikováno v:
In IFAC Proceedings Volumes March-April 2000 33(3):307-312
Autor:
Erdmann, Erland, Dormandy, John, Wilcox, Robert, Massi-Benedetti, Massimo, Charbonnel, Bernard
Publikováno v:
Vascular Health and Risk Management
Patients with type 2 diabetes face an increased risk of macrovascular disease compared to those without. Significant reductions in the risk of major cardiovascular events can be achieved with appropriate drug therapy, although patients with type 2 di